An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria-Reference-Cited by-同舟云学术

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

Published:2022-01-02 Issue:1 Volume:18 Page:39-59
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Pernaute-Lau Leyre¹²,Camara Mahamadou³,Nóbrega de Sousa Taís⁴,Morris Ulrika¹,Ferreira Marcelo Urbano²⁵,Gil José Pedro¹²⁶

Affiliation:

1. Department of Microbiology, Tumor and Cell biology, Karolinska Institutet, Solna, Sweden

2. Faculty of Sciences, BioISI - Biosystems & Integrative Sciences Institute, University of Lisbon, Lisbon, 1749-016, Portugal

3. Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali

4. Molecular Biology and Malaria Immunology Research Group, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Brasil

5. Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

6. Global Health and Tropical Medicine, Institute of Hygiene and Tropical Medicine, Nova University of Lisbon, Portugal

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

European and Developing Countries Clinical Trials Partnership

Fundação de Amparo *a Pesquisa do Estado de mInas Gerais

Fundação para a Ciência e Tecnologia

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2022.2049235

Reference255 articles.

1. The pharmacogenetics of antimalaria artemisinin combination therapy

2. MMV-supported projects [Internet]. Geneva: Medicines for Malaria Venture; [cited 2021 Jun 08]. Available from: https://www.mmv.org/research-development/mmv-supported-projects

3. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

4. Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic efficacy of generic artemether–lumefantrine in the treatment of uncomplicated malaria in Ghana: assessing anti-malarial efficacy amidst pharmacogenetic variations;Malaria Journal;2024-04-29

2. Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences;Human Genomics;2024-04-22

3. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles;International Journal of Molecular Sciences;2023-02-08

4. Neurobehavioral and biochemical responses to artemisinin-based drug and aflatoxin B1 co-exposure in rats;Mycotoxin Research;2023-01-26

5. Biomarkers of the Toxic Effects of Chemotherapeutic Agents: A Focus on Antimalarials;Biomarkers in Toxicology;2023